Pay in 4 interest-free payments of $5.30 Learn more
Ships within 48 hours · Estimated delivery Aug 17 - Aug 22
It is worth highlighting that BPC-157's relation with nerve growth factor 1-A binding protein-2 may exert inhibitory action on specific elements
For the complete mechanistic comparison between BPC-157 and TB-500, see the TB-500 vs BPC-157 research peptide comparison guide on the Ascend Peptides UK research blog
No signup, no email required, no paywalls
TB-500 resets the inflammatory environment throughout the body
The FDA has not approved BPC-157 as a drug, biologic, or dietary supplement ingredient for any medical indication, positioning the peptide outside the boundaries of legal pharmaceutical commerce for human administration
Angiogenic and growth-factor signaling In rat models of muscle and tendon injury, BPC-157 administration has been associated with up-regulated VEGF expression and accelerated formation of granulation tissue and new microvasculature relative to controls (Brcic et al., 2009
US$ 21.76
US$ 29.15
US$ 22.62
US$ 29.32
US$ 23.42
